To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene HSD11B1LandRPL36TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
468 representative clones for gene HSD11B1LandRPL36 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR622145 adult brain .a 1 to 1884 1 to 1884 exact tiling clone,   1884/1884
(100 %)
0 diff
(100 %id)
BX453754 adult brain, brain .a 351 to 1071 721 to 1       721/943
(76 %)
12 diff
(98.8 %id)
AK308206 small intestine .b 1 to 1687 1 to 1688 A231C L232A D233G G234R F235L ... tiling clone,   1688/1688
(100 %)
1 diff
(100.0 %id)
BG108181 Bone, osteosarcoma, cell line .c 374 to 1062 1 to 690   tiling clone,   690/690
(100 %)
1 diff
(99.9 %id)
BI084221 epidermoid carcinoma, cell line, salivary gland .c 504 to 935 2 to 433   fully sequenced,   432/433
(99 %)
6 diff
(98.7 %id)
AL562863 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 519 to 1331 810 to 1       810/818
(99 %)
19 diff
(97.7 %id)
TI_1948236650   .c 519 to 873 960 to 607     Submitted on the opposite strand 354/1419
(24 %)
13 diff
(99.1 %id)
TI_1948236651   .c 546 to 873 945 to 604     Submitted on the opposite strand 342/1285
(26 %)
26 diff
(98.0 %id)
TI_57243027   .c 812 to 1424 89 to 713       625/717
(87 %)
8 diff
(98.9 %id)
EL949694 eyeball .c 863 to 1412 1 to 550       550/550
(100 %)
3 diff
(99.5 %id)
BQ188255 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 902 to 1446 1 to 549   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 549/549
(100 %)
3 diff
(99.5 %id)
CR738280   .c 904 to 1446 557 to 15   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 543/543
(100 %)
0 diff
(100 %id)
BI084713 epidermoid carcinoma, cell line, salivary gland .c 905 to 1395 493 to 1   fully sequenced,   493/493
(100 %)
3 diff
(99.4 %id)
DB569895 hypothalamus .c 922 to 1446 1 to 525     Submitted on the opposite strand 525/525
(100 %)
1 diff
(99.9 %id)
AW205736   .c 938 to 1446 526 to 18   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 509/509
(100 %)
3 diff
(99.5 %id)
TI_154088490   .c 968 to 1447 673 to 191   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 483/1299
(37 %)
0 diff
(100 %id)
AA227798 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 975 to 1403 1 to 429       429/429
(100 %)
2 diff
(99.6 %id)
DB550275 hippocampus .c 976 to 1446 1 to 471     Submitted on the opposite strand 471/471
(100 %)
1 diff
(99.8 %id)
AI761851 pooled .c 976 to 1445 470 to 1       470/470
(100 %)
0 diff
(100 %id)
AI871311 anaplastic oligodendroglioma, brain .c 992 to 1448 457 to 1   tiling clone,   457/457
(100 %)
3 diff
(99.4 %id)
AI884864 anaplastic oligodendroglioma, brain .c 992 to 1448 457 to 1       457/457
(100 %)
2 diff
(99.6 %id)
AI983643 adenocarcinoma, Pancreas .c 996 to 1446 463 to 13   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 451/451
(100 %)
5 diff
(98.9 %id)
DB528482 hippocampus .c 1001 to 1446 1 to 446     Submitted on the opposite strand 446/446
(100 %)
4 diff
(99.2 %id)
DB560401 hypothalamus .c 1011 to 1446 1 to 436     Submitted on the opposite strand 436/436
(100 %)
6 diff
(98.7 %id)
DB519494 testis .c 1021 to 1446 1 to 427     Submitted on the opposite strand 427/428
(99 %)
10 diff
(97.7 %id)
DB562944 hypothalamus .c 1028 to 1446 1 to 418     Submitted on the opposite strand 418/418
(100 %)
3 diff
(99.3 %id)
BM873446   .c 1031 to 1447 418 to 2       417/418
(99 %)
0 diff
(100 %id)
AI423783 brain, glioblastoma (pooled) .c 1049 to 1446 398 to 1       398/398
(100 %)
0 diff
(100 %id)
R43210 whole brain .c 1061 to 1446 404 to 12   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 393/393
(100 %)
7 diff
(98.3 %id)
AA707428   .c 1095 to 1447 369 to 17     Submitted on the opposite strand 353/369
(95 %)
0 diff
(100 %id)
CD107574 brain, Pituitary .c 1106 to 1446 1 to 341       341/440
(77 %)
1 diff
(99.8 %id)
AI241742 brain, tumor, 5 pooled (see description) .c 1111 to 1446 352 to 17   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 336/336
(100 %)
0 diff
(100 %id)
AI919490 anaplastic oligodendroglioma, brain .c 1136 to 1448 313 to 1       313/313
(100 %)
1 diff
(99.7 %id)
AJ574447 pectoral muscle (after mastectomy) .c 1140 to 1446 1 to 306       306/314
(97 %)
8 diff
(97.5 %id)
AI263206 Kidney .c 1142 to 1446 305 to 1       305/399
(76 %)
5 diff
(98.8 %id)
BE858983 Prostate .c 1193 to 1447 255 to 1       255/255
(100 %)
0 diff
(100 %id)
CA336430 posterior rhombomeres 5-8 (4 pooled) .c 1206 to 1446 1 to 241   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 241/241
(100 %)
0 diff
(100 %id)
AI864111 pooled .c 1217 to 1445 230 to 1       230/230
(100 %)
1 diff
(99.6 %id)
DB567316 hypothalamus .c 1245 to 1446 1 to 202     Submitted on the opposite strand 202/202
(100 %)
6 diff
(97.1 %id)
AY313894   .d 1 to 1524 1 to 1524 exact tiling clone, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 1524/1524
(100 %)
0 diff
(100 %id)
NM_198533.1   .d 1 to 1524 1 to 1524 exact RefSeq, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 1524/1524
(100 %)
0 diff
(100 %id)
BM543550 brain, hippocampus .d 29 to 660 25 to 656       632/1102
(57 %)
7 diff
(99.4 %id)
BI829131 brain, medulla .d 123 to 997 1 to 872       874/872
(100 %)
8 diff
(99.1 %id)
TI_57175849   .d 123 to 997 29 to 900       874/900
(97 %)
14 diff
(98.5 %id)
BX418901 brain, fetal brain .d 126 to 928 1 to 804       804/942
(85 %)
7 diff
(99.3 %id)
CB993586 placenta, pre-eclamptic placenta .d 137 to 746 28 to 640       613/884
(69 %)
21 diff
(97.7 %id)
AY268352   .e 1 to 1659 1 to 1659 exact tiling clone, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 1659/1659
(100 %)
0 diff
(100 %id)
NM_198706.1   .e 1 to 1659 1 to 1659 exact RefSeq, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 1659/1659
(100 %)
0 diff
(100 %id)
BC072434 Brain, hippocampus .f 1 to 1532 1 to 1532 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 1532/1532
(100 %)
0 diff
(100 %id)
BG716680 brain, hypothalamus .g 1 to 785 1 to 782       782/859
(91 %)
15 diff
(98.3 %id)
BC094798 Brain, hypothalamus .g 6 to 1544 1 to 1539 T23A tiling clone, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 1539/1539
(100 %)
2 diff
(99.9 %id)
BM548484 brain, hippocampus .g 58 to 622 1 to 566       566/1243
(45 %)
5 diff
(99.6 %id)
DB469531 hippocampus .g 59 to 776 1 to 716       716/718
(99 %)
15 diff
(98.0 %id)
BG178580 adenocarcinoma, cell line, Prostate .g 270 to 1083 8 to 823 Q153H A171G R172A G173R R174P ... tiling clone,   816/1115
(73 %)
50 diff
(95.6 %id)
TI_891527601   .g 423 to 1006 46 to 629       584/1189
(49 %)
8 diff
(99.4 %id)
TI_891527605   .g 423 to 1006 45 to 628       584/1187
(49 %)
8 diff
(99.4 %id)
TI_891527609   .g 423 to 1006 647 to 64       584/1192
(48 %)
0 diff
(100 %id)
TI_891527613   .g 423 to 1006 646 to 63       584/1216
(48 %)
0 diff
(100 %id)
TI_1242414662   .g 423 to 1003 634 to 54     Submitted on the opposite strand 581/1177
(49 %)
0 diff
(100 %id)
TI_1242418540   .g 423 to 1003 641 to 61     Submitted on the opposite strand 581/853
(68 %)
0 diff
(100 %id)
BC093950 Brain, cerebellum, PCR rescued clones .g 423 to 1003 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BC112187 Brain, cerebellum, PCR rescued clones .g 423 to 1003 1 to 581       581/581
(100 %)
0 diff
(100 %id)
TI_57150296   .g 449 to 925 54 to 531       478/531
(90 %)
8 diff
(98.5 %id)
BI763069 pooled colon, kidney, stomach .g 456 to 925 1 to 471       471/471
(100 %)
3 diff
(99.4 %id)
BX422880 adult brain, brain .g 503 to 1516 1001 to 1       1003/1059
(94 %)
28 diff
(97.4 %id)
EL737105 mixed .g 510 to 971 1 to 462       462/565
(81 %)
3 diff
(99.5 %id)
BX454914 brain, fetal brain .g 773 to 1540 768 to 1       768/921
(83 %)
18 diff
(98.1 %id)
DB537117 hippocampus .g 824 to 1544 1 to 719     Submitted on the opposite strand 719/719
(100 %)
19 diff
(97.4 %id)
BI916458 brain .g 849 to 1522 1 to 686       686/690
(99 %)
29 diff
(95.8 %id)
BU625646 cell lines, Enchondroma .g 893 to 1544 668 to 19   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 650/650
(100 %)
3 diff
(99.6 %id)
AI955289 brain, four pooled pituitary adenomas .g 904 to 1544 641 to 1   tiling clone,   641/641
(100 %)
9 diff
(98.6 %id)
AY268354   .h 1 to 1547 1 to 1547 exact tiling clone, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 1547/1547
(100 %)
0 diff
(100 %id)
NM_198708.1   .h 1 to 1547 1 to 1547 exact RefSeq, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 1547/1547
(100 %)
0 diff
(100 %id)
BC053546 Brain, hippocampus .h 72 to 1547 1 to 1476 exact available from MGC, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 1476/1476
(100 %)
0 diff
(100 %id)
BM728992 eye, fetal eye .h 114 to 671 1 to 557     Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 557/557
(100 %)
1 diff
(99.9 %id)
BM681938 eye, fetal eye .h 940 to 1547 625 to 19   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 607/607
(100 %)
1 diff
(99.9 %id)
AY313896   .i 1 to 1293 1 to 1293 exact tiling clone, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 1293/1293
(100 %)
0 diff
(100 %id)
AW162782 brain, frontal lobe .j 1 to 506 1 to 508   tiling clone,   508/531
(95 %)
23 diff
(95.7 %id)
AW163684 brain, frontal lobe .j 1 to 499 1 to 496   tiling clone,   496/653
(75 %)
9 diff
(98.7 %id)
AW162676 brain, frontal lobe .j 988 to 1457 477 to 8   tiling clone,   470/477
(98 %)
0 diff
(100 %id)
AW163083 brain, frontal lobe .j 1122 to 1457 343 to 8       336/343
(97 %)
0 diff
(100 %id)
BU528486 epidermoid carcinoma, cell line, lung .k 1 to 524 69 to 601   tiling clone,   533/1082
(49 %)
24 diff
(97.8 %id)
BM546084 ovary (pool of 3) .k 515 to 1275 9 to 774   tiling clone,   766/1154
(66 %)
6 diff
(99.5 %id)
CR980348 T-Lymphocytes .k 516 to 1158 1 to 644   tiling clone,   644/649
(99 %)
2 diff
(99.7 %id)
CN306602 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 1189 to 1722 1 to 534   tiling clone,   534/534
(100 %)
0 diff
(100 %id)
BG704408 brain, hippocampus .l 1 to 780 1 to 771   tiling clone,   771/836
(92 %)
23 diff
(97.3 %id)
DB466310 hippocampus .l 6 to 433 1 to 428       428/431
(99 %)
32 diff
(92.6 %id)
DA343367 substantia nigra .l 168 to 767 2 to 601   tiling clone, capped   600/600
(100 %)
0 diff
(100 %id)
BI669671 brain, hypothalamus .l 455 to 1156 1 to 701   tiling clone,   701/701
(100 %)
6 diff
(99.2 %id)
CB154479 brain .l 457 to 921 1 to 466       466/469
(99 %)
8 diff
(98.3 %id)
TI_44344204   .l 460 to 1156 90 to 785       696/785
(88 %)
7 diff
(99.2 %id)
DR001951 fetal brain .l 559 to 1002 8 to 450       443/450
(98 %)
7 diff
(98.5 %id)
TI_57190711   .l 1041 to 1227 57 to 243   tiling clone,   664/858
(77 %)
27 diff
(96.9 %id)
DB489922 hypothalamus .m 1 to 438 7 to 444       444/444
(100 %)
1 diff
(99.8 %id)
CB991111 placenta, pre-eclamptic placenta .m 1 to 766 29 to 797   tiling clone,   770/801
(96 %)
22 diff
(97.3 %id)
TI_57201664   .m 252 to 1075 22 to 843       822/843
(97 %)
9 diff
(99.0 %id)
AY268351   .m 259 to 1714 1 to 1456 exact tiling clone, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 1456/1456
(100 %)
0 diff
(100 %id)
BI821921 pooled brain, lung, testis .m 259 to 1075 1 to 815       815/815
(100 %)
4 diff
(99.6 %id)
NM_198705.1   .m 259 to 1714 1 to 1456 exact RefSeq, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 1456/1456
(100 %)
0 diff
(100 %id)
DB496294 hypothalamus .m 407 to 717 1 to 311       311/311
(100 %)
2 diff
(99.4 %id)
DB454053 testis .m 409 to 877 1 to 469       469/469
(100 %)
0 diff
(100 %id)
CN370318 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .m 416 to 926 1 to 511       511/511
(100 %)
3 diff
(99.5 %id)
CX865680 embryonic stem .n 1 to 636 1 to 636   tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 636/636
(100 %)
0 diff
(100 %id)
CX865604 embryonic stem .n 606 to 1229 651 to 28   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 624/624
(100 %)
1 diff
(99.9 %id)
BM807422 brain, hippocampus .o 1 to 737 11 to 757   tiling clone,   745/1227
(60 %)
25 diff
(98.0 %id)
TI_57219024   .o 13 to 985 61 to 1025       965/1028
(93 %)
45 diff
(95.7 %id)
BI754054 brain .o 16 to 985 1 to 962   tiling clone,   962/965
(99 %)
39 diff
(96.0 %id)
DT218534 brain .o 25 to 628 1 to 604   tiling clone,   604/604
(100 %)
0 diff
(100 %id)
BG490328 large cell carcinoma, lung .o 51 to 796 1 to 744   tiling clone,   744/744
(100 %)
8 diff
(99.0 %id)
CN294132 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o 175 to 455 1 to 281       281/281
(100 %)
3 diff
(99.0 %id)
AY268353   .p 1 to 1619 1 to 1619 exact tiling clone, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 1619/1619
(100 %)
0 diff
(100 %id)
NM_198707.1   .p 1 to 1619 1 to 1619 exact RefSeq, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 1619/1619
(100 %)
0 diff
(100 %id)
CB053976 brain, glioblastoma (pooled) .p 169 to 834 9 to 674       666/674
(98 %)
7 diff
(99.0 %id)
CB053975 brain, glioblastoma (pooled) .p 1037 to 1609 615 to 43   AAA   573/583
(98 %)
0 diff
(100 %id)
BE906883 epithelioid carcinoma, Pancreas .q 1 to 777 1 to 776   tiling clone,   776/875
(88 %)
16 diff
(98.2 %id)
EC581972 Prostate .q 464 to 566 1 to 103       103/103
(100 %)
0 diff
(100 %id)
EC490755 Prostate .q 466 to 566 2 to 105       104/105
(99 %)
6 diff
(94.3 %id)
BM760417 lymph node, stomach .q 476 to 681 1 to 206       206/206
(100 %)
0 diff
(100 %id)
BM746170 stomach .q 480 to 584 1 to 106       106/111
(95 %)
2 diff
(98.2 %id)
CB148410 Liver .q 484 to 625 1 to 142       142/142
(100 %)
0 diff
(100 %id)
EC509088 Prostate .q 486 to 593 1 to 108       108/108
(100 %)
0 diff
(100 %id)
EC491657 Prostate .q 498 to 601 6 to 109       104/109
(95 %)
5 diff
(95.5 %id)
EC517171 Prostate .q 498 to 591 16 to 111       96/111
(86 %)
9 diff
(91.9 %id)
EC541609 Prostate .q 498 to 601 1 to 104       104/104
(100 %)
0 diff
(100 %id)
AA375705 lung .q 499 to 745 1 to 247       247/247
(100 %)
3 diff
(98.8 %id)
BF947378 nervous_normal .q 503 to 666 176 to 14       163/187
(87 %)
4 diff
(97.9 %id)
EC463705 Prostate .q 503 to 604 1 to 102       102/102
(100 %)
0 diff
(100 %id)
DW424514 Liver .q 504 to 761 11 to 268   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 258/270
(95 %)
8 diff
(97.1 %id)
DW432889 Liver .q 504 to 756 11 to 264       254/264
(96 %)
13 diff
(95.1 %id)
EC490993 Prostate .q 505 to 596 1 to 90       90/94
(95 %)
6 diff
(93.7 %id)
EC491186 Prostate .q 505 to 596 1 to 90       90/94
(95 %)
6 diff
(93.7 %id)
EC557082 Prostate .q 505 to 601 11 to 107       97/107
(90 %)
6 diff
(94.4 %id)
CN306599 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .q 507 to 762 1 to 256       256/256
(100 %)
3 diff
(98.9 %id)
EC510076 Prostate .q 507 to 604 1 to 98       98/98
(100 %)
0 diff
(100 %id)
CA455258 mixed (pool of 40 RNAs) .q 507 to 764 1 to 258   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 258/261
(98 %)
3 diff
(98.9 %id)
EC538574 Prostate .q 508 to 604 1 to 97       97/97
(100 %)
2 diff
(98.0 %id)
EC507813 Prostate .q 510 to 604 8 to 102       95/102
(93 %)
10 diff
(90.2 %id)
N86756   .q 510 to 627 1 to 117       117/117
(100 %)
6 diff
(94.9 %id)
F27370 pectoral muscle (after mastectomy) .q 510 to 773 1 to 264       264/264
(100 %)
3 diff
(98.9 %id)
EC548981 Prostate .q 511 to 604 1 to 95       95/95
(100 %)
4 diff
(95.8 %id)
BM147202 leukopheresis .q 511 to 719 1 to 209       209/210
(99 %)
6 diff
(97.2 %id)
EC504381 Prostate .q 514 to 604 1 to 91       91/91
(100 %)
1 diff
(99.0 %id)
EC504609 Prostate .q 514 to 604 1 to 91       91/91
(100 %)
1 diff
(99.0 %id)
DW441461 Liver .q 515 to 734 19 to 238       220/238
(92 %)
8 diff
(96.7 %id)
DW450954 Liver .q 515 to 691 19 to 195       177/195
(90 %)
13 diff
(93.4 %id)
BQ306166 breast .q 516 to 687 1 to 173       173/173
(100 %)
10 diff
(94.3 %id)
CN306590 embryonic stem cells, DMSO-treated H9 cellline .q 517 to 972 5 to 460   tiling clone,   456/460
(99 %)
8 diff
(98.3 %id)
CN306606 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .q 518 to 695 1 to 178       178/178
(100 %)
3 diff
(98.4 %id)
EC491910 Prostate .q 518 to 615 1 to 98       98/102
(96 %)
5 diff
(95.1 %id)
EC512916 Prostate .q 518 to 620 1 to 104       104/104
(100 %)
2 diff
(98.1 %id)
EC523095 Prostate .q 518 to 620 1 to 105       105/105
(100 %)
4 diff
(96.2 %id)
EC533032 Prostate .q 519 to 620 1 to 101       101/101
(100 %)
2 diff
(98.1 %id)
AA371889 pituitary gland .q 520 to 766 1 to 246       246/246
(100 %)
1 diff
(99.6 %id)
AA373707 lung .q 520 to 749 1 to 230       230/230
(100 %)
3 diff
(98.7 %id)
AJ572588 pectoral muscle (after mastectomy) .q 520 to 683 1 to 164       164/164
(100 %)
0 diff
(100 %id)
AJ574090 pectoral muscle (after mastectomy) .q 520 to 626 1 to 108       108/108
(100 %)
1 diff
(99.1 %id)
AJ714358 bone marrow .q 520 to 621 14 to 115       102/115
(88 %)
6 diff
(94.8 %id)
EC450100 Prostate .q 520 to 615 1 to 96       96/105
(91 %)
1 diff
(99.1 %id)
EC475399 Prostate .q 520 to 620 1 to 101       101/101
(100 %)
1 diff
(99.1 %id)
EC484462 Prostate .q 520 to 620 1 to 101       101/101
(100 %)
1 diff
(99.1 %id)
EC496963 Prostate .q 520 to 615 1 to 93       93/97
(95 %)
4 diff
(95.9 %id)
EC533150 Prostate .q 520 to 620 1 to 101       101/101
(100 %)
1 diff
(99.1 %id)
AJ574402 pectoral muscle (after mastectomy) .q 521 to 683 11 to 173       163/173
(94 %)
6 diff
(96.6 %id)
EC543098 Prostate .q 521 to 622 1 to 102       102/102
(100 %)
1 diff
(99.1 %id)
EC582771 Prostate .q 522 to 622 1 to 101       101/101
(100 %)
0 diff
(100 %id)
AA301081 testis .q 524 to 694 1 to 170       170/170
(100 %)
3 diff
(98.3 %id)
EC562974 Prostate .q 524 to 622 1 to 99       99/99
(100 %)
0 diff
(100 %id)
AA318610 Spleen .q 526 to 709 1 to 183       183/183
(100 %)
5 diff
(97.3 %id)
AA603246   .q 526 to 622 8 to 102       95/102
(93 %)
8 diff
(92.2 %id)
AA358130 lung .q 527 to 780 1 to 264       264/280
(94 %)
15 diff
(94.7 %id)
EC458584 Prostate .q 527 to 623 1 to 97       97/99
(97 %)
2 diff
(98.0 %id)
T25773   .q 527 to 728 1 to 193       195/204
(95 %)
7 diff
(96.6 %id)
AJ714736 bone marrow .q 528 to 613 22 to 107       86/107
(80 %)
6 diff
(94.4 %id)
EC466421 Prostate .q 529 to 623 1 to 95       95/100
(95 %)
2 diff
(98.0 %id)
EC475409 Prostate .q 531 to 630 3 to 102       100/102
(98 %)
0 diff
(100 %id)
BM844231 lymph node, stomach .q 531 to 774 1 to 237       237/239
(99 %)
12 diff
(95.0 %id)
EC445681 Prostate .q 532 to 623 1 to 91       91/102
(89 %)
3 diff
(97.1 %id)
EC445707 Prostate .q 532 to 623 1 to 92       92/103
(89 %)
2 diff
(98.1 %id)
EC475297 Prostate .q 532 to 623 1 to 92       92/103
(89 %)
2 diff
(98.1 %id)
EC524621 Prostate .q 532 to 623 1 to 90       90/100
(90 %)
4 diff
(96.0 %id)
EC547834 Prostate .q 532 to 623 1 to 92       92/103
(89 %)
2 diff
(98.1 %id)
EC576401 Prostate .q 532 to 623 1 to 92       92/103
(89 %)
2 diff
(98.1 %id)
EC576555 Prostate .q 532 to 623 1 to 92       92/103
(89 %)
2 diff
(98.1 %id)
AA344773 gall bladder .q 533 to 694 1 to 161       161/161
(100 %)
3 diff
(98.2 %id)
AJ572823 pectoral muscle (after mastectomy) .q 539 to 627 9 to 97       89/97
(91 %)
0 diff
(100 %id)
EC449543 Prostate .q 539 to 623 13 to 94       82/99
(82 %)
5 diff
(95.0 %id)
EC460279 Prostate .q 539 to 623 9 to 93       85/104
(81 %)
2 diff
(98.1 %id)
EC462732 Prostate .q 539 to 627 17 to 105       89/105
(84 %)
6 diff
(94.3 %id)
EC485212 Prostate .q 540 to 641 1 to 102       102/102
(100 %)
0 diff
(100 %id)
BI001632 head_normal .q 544 to 715 13 to 185       173/192
(90 %)
10 diff
(94.8 %id)
F24689 pectoral muscle (after mastectomy) .q 545 to 623 1 to 79       79/79
(100 %)
0 diff
(100 %id)
AA559980 Prostate, prostatic intraepithelial neoplasia - highgrade .q 546 to 706 7 to 166       160/166
(96 %)
8 diff
(95.2 %id)
EC484956 Prostate .q 547 to 655 1 to 109       109/109
(100 %)
0 diff
(100 %id)
EC448411 Prostate .q 549 to 637 1 to 88       88/108
(81 %)
2 diff
(98.2 %id)
EC532106 Prostate .q 549 to 658 1 to 110       110/110
(100 %)
0 diff
(100 %id)
EC575867 Prostate .q 550 to 658 1 to 108       108/108
(100 %)
1 diff
(99.1 %id)
EC478323 Prostate .q 552 to 662 1 to 110       110/110
(100 %)
2 diff
(98.2 %id)
EC443860 Prostate .q 553 to 662 1 to 111       111/111
(100 %)
4 diff
(96.4 %id)
EC544739 Prostate .q 554 to 662 1 to 108       108/108
(100 %)
1 diff
(99.1 %id)
EC569532 Prostate .q 554 to 662 1 to 109       109/109
(100 %)
0 diff
(100 %id)
EC456810 Prostate .q 557 to 662 7 to 112       106/112
(94 %)
6 diff
(94.7 %id)
EC449062 Prostate .q 558 to 662 7 to 111       105/111
(94 %)
6 diff
(94.6 %id)
EC574832 Prostate .q 560 to 667 1 to 108       108/108
(100 %)
0 diff
(100 %id)
AA580471 colon, colon tumor .q 560 to 614 54 to 1       54/54
(100 %)
1 diff
(98.2 %id)
AA662018 alveolar rhabdomyosarcoma .q 574 to 696 1 to 123       123/124
(99 %)
7 diff
(94.4 %id)
EC545335 Prostate .q 652 to 764 1 to 110       110/110
(100 %)
10 diff
(91.0 %id)
BE762347 denis_drash .q 664 to 771 110 to 1       110/114
(96 %)
4 diff
(96.5 %id)
AY313895   .r 1 to 1361 1 to 1361 exact tiling clone, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 1361/1361
(100 %)
0 diff
(100 %id)
NM_198704.1   .r 1 to 1361 1 to 1361 exact RefSeq, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 1361/1361
(100 %)
0 diff
(100 %id)
CR607228 Placenta Cot 25-normalized .s 1 to 1319 1 to 1319 exact tiling clone,   1319/1319
(100 %)
0 diff
(100 %id)
BP432113   .t 1 to 320 5 to 324       324/324
(100 %)
4 diff
(98.8 %id)
BP432264   .t 1 to 343 4 to 346   tiling clone,   346/346
(100 %)
3 diff
(99.2 %id)
CB125913 Liver .t 2 to 307 1 to 306       306/306
(100 %)
3 diff
(99.1 %id)
CB114493 Liver .t 3 to 487 1 to 485       485/485
(100 %)
1 diff
(99.8 %id)
CB120116 Liver .t 3 to 425 1 to 423       423/423
(100 %)
1 diff
(99.8 %id)
CB125304 Liver .t 3 to 503 1 to 501       501/501
(100 %)
0 diff
(100 %id)
CB124961 Liver .t 3 to 540 1 to 538 S146F AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 538/538
(100 %)
1 diff
(99.9 %id)
CB124653 Liver .t 3 to 485 1 to 483       483/483
(100 %)
3 diff
(99.4 %id)
CB124381 Liver .t 3 to 540 1 to 538 S146F     538/538
(100 %)
1 diff
(99.9 %id)
CB124391 Liver .t 3 to 540 1 to 538 S146F AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 538/538
(100 %)
1 diff
(99.9 %id)
CB124190 Liver .t 3 to 487 1 to 485       485/485
(100 %)
0 diff
(100 %id)
CB125175 Liver .t 3 to 540 1 to 538 S146F AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 538/538
(100 %)
1 diff
(99.9 %id)
CB125228 Liver .t 3 to 540 1 to 538 S146F AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 538/538
(100 %)
1 diff
(99.9 %id)
CB125412 Liver .t 3 to 138 1 to 136       136/136
(100 %)
2 diff
(98.6 %id)
CB125114 Liver .t 3 to 540 1 to 538 S146F AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 538/538
(100 %)
1 diff
(99.9 %id)
CB125145 Liver .t 3 to 540 1 to 538 S146F AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 538/538
(100 %)
1 diff
(99.9 %id)
CB126477 Liver .t 3 to 485 1 to 482       482/482
(100 %)
1 diff
(99.8 %id)
CB126657 Liver .t 3 to 403 1 to 402       402/402
(100 %)
3 diff
(99.3 %id)
CB126694 Liver .t 3 to 440 1 to 438       438/438
(100 %)
0 diff
(100 %id)
CB126906 Liver .t 3 to 362 1 to 360       360/360
(100 %)
1 diff
(99.8 %id)
CB126174 Liver .t 3 to 364 1 to 362       362/362
(100 %)
1 diff
(99.8 %id)
CB125474 Liver .t 3 to 515 1 to 513       513/513
(100 %)
0 diff
(100 %id)
CB125895 Liver .t 3 to 540 1 to 538 E95A S146F AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 538/538
(100 %)
3 diff
(99.5 %id)
CB125917 Liver .t 3 to 540 1 to 538 C135* AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 538/538
(100 %)
2 diff
(99.7 %id)
CB125641 Liver .t 3 to 523 1 to 521       521/521
(100 %)
1 diff
(99.9 %id)
CB125700 Liver .t 3 to 544 1 to 542 S146F     542/547
(99 %)
3 diff
(99.5 %id)
CB125721 Liver .t 3 to 539 1 to 537 S146F     537/537
(100 %)
1 diff
(99.9 %id)
CB125733 Liver .t 3 to 540 1 to 538 S146F AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 538/538
(100 %)
1 diff
(99.9 %id)
CB125843 Liver .t 3 to 527 1 to 525 G99R E118D A120S R126P S142C ...     525/525
(100 %)
7 diff
(98.7 %id)
CB126227 Liver .t 3 to 482 1 to 480       480/480
(100 %)
2 diff
(99.6 %id)
CB126236 Liver .t 3 to 465 1 to 463       463/463
(100 %)
0 diff
(100 %id)
CB126292 Liver .t 3 to 540 1 to 538 S146F AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 538/538
(100 %)
1 diff
(99.9 %id)
CB127114 Liver .t 3 to 540 1 to 538 S146F AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 538/538
(100 %)
1 diff
(99.9 %id)
TI_59394219   .t 7 to 548 86 to 627 exact     542/542
(100 %)
0 diff
(100 %id)
BM686732 eye, optic nerve .t 7 to 544 8 to 545 exact fully sequenced, Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 538/545
(98 %)
7 diff
(98.8 %id)
BM015858 breast, mammary adenocarcinoma, cell line .t 8 to 548 1 to 541 exact     541/541
(100 %)
0 diff
(100 %id)
NM_015414.3   .t 8 to 542 1 to 535 exact RefSeq, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 535/535
(100 %)
0 diff
(100 %id)
BM925452 brain .t 9 to 540 13 to 544 exact AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 532/546
(97 %)
6 diff
(99.0 %id)
BM562098 leukocyte .t 10 to 542 10 to 543 R73C AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 534/543
(98 %)
8 diff
(98.6 %id)
CN306594 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .t 14 to 542 1 to 529 exact AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 529/529
(100 %)
0 diff
(100 %id)
BQ279064 adenocarcinoma, cell line, breast .t 18 to 542 1 to 525 exact AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 525/525
(100 %)
0 diff
(100 %id)
AA372830 lung .t 21 to 260 1 to 240       240/240
(100 %)
0 diff
(100 %id)
BC003052 Skin, melanotic melanoma. .t 29 to 542 1 to 514 exact available from MGC, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 514/514
(100 %)
0 diff
(100 %id)
BU782041 insulinoma, Pancreas .t 29 to 304 4 to 279   fully sequenced,   276/279
(98 %)
6 diff
(97.9 %id)
BX416917 placenta .t 30 to 544 34 to 548 exact     515/548
(93 %)
6 diff
(99.0 %id)
AF077043   .t 36 to 542 1 to 507 exact AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 507/508
(99 %)
2 diff
(99.7 %id)
BM809447 amelanotic melanoma, cell line, skin .t 36 to 542 24 to 530 exact AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 507/530
(95 %)
6 diff
(98.9 %id)
AA628531   .t 60 to 542 505 to 24 L26F G41A R42V P44L Q45N ... AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 482/482
(100 %)
11 diff
(97.8 %id)
BI862490 breast, mammary adenocarcinoma, cell line .t 73 to 542 1 to 470 exact AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 470/470
(100 %)
0 diff
(100 %id)
TI_57192666   .t 73 to 542 55 to 524 exact AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 470/470
(100 %)
0 diff
(100 %id)
BE277177 melanotic melanoma, skin .t 74 to 543 46 to 516 S50K D51*     471/516
(91 %)
8 diff
(98.5 %id)
AI148106 uterus .t 93 to 544 458 to 7       452/458
(98 %)
0 diff
(100 %id)
AI735002 colon .t 99 to 540 442 to 1       442/442
(100 %)
0 diff
(100 %id)
AI703215 pooled .t 103 to 543 441 to 1       441/441
(100 %)
0 diff
(100 %id)
AI813679 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .t 117 to 544 428 to 1       428/428
(100 %)
2 diff
(99.6 %id)
AI218297 pooled .t 154 to 543 390 to 1       390/390
(100 %)
1 diff
(99.8 %id)
DN991938 brain, whole brain .t 159 to 542 1 to 386   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 386/386
(100 %)
7 diff
(98.2 %id)
AJ708996 heart .t 168 to 652 20 to 504       485/504
(96 %)
6 diff
(98.9 %id)
BF114896 fibrotheoma, ovary .t 170 to 542 385 to 13   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 373/373
(100 %)
0 diff
(100 %id)
BE274547 melanotic melanoma, skin .t 179 to 541 1 to 363       363/363
(100 %)
0 diff
(100 %id)
CR533465   .t 181 to 510 1 to 330       330/330
(100 %)
0 diff
(100 %id)
CN306587 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .t 182 to 540 1 to 359   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 359/359
(100 %)
0 diff
(100 %id)
BE900218 choriocarcinoma, placenta .t 182 to 542 1 to 361       361/361
(100 %)
0 diff
(100 %id)
CN306595 embryonic stem cells, DMSO-treated H9 cellline .t 183 to 538 1 to 356       356/356
(100 %)
0 diff
(100 %id)
CN306605 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .t 183 to 537 1 to 355       355/355
(100 %)
0 diff
(100 %id)
BG491231 amelanotic melanoma, cell line, skin .t 184 to 542 1 to 359   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 359/359
(100 %)
0 diff
(100 %id)
CN306591 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .t 185 to 542 1 to 358   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 358/358
(100 %)
0 diff
(100 %id)
CN306609 embryonic stem cells, DMSO-treated H9 cellline .t 185 to 542 1 to 358   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 358/358
(100 %)
0 diff
(100 %id)
CN306620 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .t 185 to 685 1 to 501       501/505
(99 %)
1 diff
(99.9 %id)
BI833902 pooled pancreas and spleen .t 185 to 542 1 to 358   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 358/358
(100 %)
0 diff
(100 %id)
BM541778 leiomyosarcoma, uterus .t 185 to 542 1 to 358   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 358/358
(100 %)
0 diff
(100 %id)
AJ711963 heart .t 187 to 542 1 to 356   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 356/356
(100 %)
0 diff
(100 %id)
AI284407 Kidney .t 188 to 542 355 to 1       355/355
(100 %)
0 diff
(100 %id)
AJ713612 bone marrow .t 189 to 536 1 to 348       348/348
(100 %)
0 diff
(100 %id)
AJ712767 bone marrow .t 190 to 542 1 to 353   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 353/353
(100 %)
0 diff
(100 %id)
CN306588 embryonic stem cells, DMSO-treated H9 cellline .t 190 to 537 1 to 348       348/348
(100 %)
0 diff
(100 %id)
AI797882 B-cell, chronic lymphotic leukemia .t 190 to 543 354 to 1       354/354
(100 %)
0 diff
(100 %id)
BF971381 adrenal cortex carcinoma, cell line, adrenal gland .t 191 to 542 1 to 352   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 352/352
(100 %)
0 diff
(100 %id)
BM555751 amelanotic melanoma, cell line, skin .t 191 to 542 1 to 352   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 352/352
(100 %)
0 diff
(100 %id)
CD106240 brain, Pituitary .t 191 to 542 1 to 352   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 352/352
(100 %)
0 diff
(100 %id)
CD251492 brain, Pituitary .t 191 to 542 1 to 352   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 352/352
(100 %)
0 diff
(100 %id)
BM912690 amelanotic melanoma, cell line, skin .t 192 to 542 1 to 351   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 351/351
(100 %)
0 diff
(100 %id)
BQ421472 epithelioid carcinoma, Pancreas .t 193 to 542 1 to 350   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 350/350
(100 %)
0 diff
(100 %id)
AI741580 pooled .t 200 to 542 359 to 17   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 343/343
(100 %)
0 diff
(100 %id)
AA551986 normal prostatic epithelial cells, Prostate .t 205 to 542 367 to 31       337/367
(91 %)
7 diff
(98.1 %id)
DR423135 eye, Pterygium .t 212 to 540 1 to 329   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 329/329
(100 %)
0 diff
(100 %id)
AI818276 normal prostate, Prostate .t 222 to 543 322 to 1       322/322
(100 %)
0 diff
(100 %id)
BG492134 amelanotic melanoma, cell line, skin .t 243 to 495 252 to 1   fully sequenced, Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 252/252
(100 %)
3 diff
(98.9 %id)
BU782931 insulinoma, Pancreas .t 243 to 527 285 to 1   fully sequenced,   285/285
(100 %)
0 diff
(100 %id)
BM672917 eye, optic nerve .t 243 to 540 318 to 21   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 298/300
(99 %)
0 diff
(100 %id)
AA121010 lung, lung carcinoma .t 247 to 543 1 to 295   fully sequenced,   297/297
(100 %)
5 diff
(98.4 %id)
BM015824 breast, mammary adenocarcinoma, cell line .t 249 to 749 1 to 501   tiling clone, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 501/501
(100 %)
0 diff
(100 %id)
BM702745 eye, Retina Foveal and Macular .t 251 to 542 1 to 292   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 292/292
(100 %)
0 diff
(100 %id)
BU729796 eye, Retina Foveal and Macular .t 252 to 542 307 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 291/291
(100 %)
0 diff
(100 %id)
AA126459 lung, lung carcinoma .t 371 to 542 171 to 1   fully sequenced,   171/171
(100 %)
0 diff
(100 %id)
BM020217 astrocytoma grade IV, cell line, brain .u 1 to 444 1 to 445 K103T G105W D106G A107R H108T ... tiling clone, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 445/445
(100 %)
4 diff
(99.2 %id)
BU598239 mixed (pool of 40 RNAs) .u 13 to 446 1 to 434       434/438
(99 %)
3 diff
(99.4 %id)
NM_033643.2   .u 14 to 444 1 to 431   RefSeq, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 431/431
(100 %)
0 diff
(100 %id)
BM760272 lymph node, stomach .u 14 to 444 1 to 431   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 431/431
(100 %)
0 diff
(100 %id)
BM841746 lymph node, stomach .u 14 to 445 1 to 432       432/432
(100 %)
0 diff
(100 %id)
BF213628 bone marrow, from acute myelogenous leukemia .u 17 to 443 1 to 428   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 428/429
(99 %)
3 diff
(99.4 %id)
CB138706 Liver .u 17 to 442 1 to 426   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 426/426
(100 %)
2 diff
(99.6 %id)
BP871419 embryonal kidney .u 18 to 350 1 to 333       333/333
(100 %)
0 diff
(100 %id)
BM856413 stomach .u 20 to 439 1 to 420       420/420
(100 %)
2 diff
(99.6 %id)
CR616362 Placenta Cot 25-normalized .u 25 to 446 1 to 422       422/422
(100 %)
0 diff
(100 %id)
BU156941 epithelioid carcinoma, Pancreas .u 26 to 444 1 to 419   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 419/419
(100 %)
0 diff
(100 %id)
CD639393 pooled .u 28 to 442 1 to 415   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 415/417
(99 %)
2 diff
(99.6 %id)
BC091508 Blood, peripheral blood mononuclear cells(PBMC) cytoplasmic poly A RNA is pooled sample from 3 and6 hr after stimulation with PMA and Ionomycin. Thesereagents are used to activate T- cells that results inlymphokine and cytokine production. .u 31 to 442 1 to 412   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 412/414
(99 %)
1 diff
(99.8 %id)
AV717668   .u 31 to 440 1 to 410   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 410/414
(99 %)
1 diff
(99.8 %id)
BU189190 melanotic melanoma, skin .u 32 to 444 1 to 413   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 413/413
(100 %)
0 diff
(100 %id)
AW156893 brain, frontal lobe .u 33 to 444 423 to 13   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 411/412
(99 %)
7 diff
(98.4 %id)
CN306603 embryonic stem cells, DMSO-treated H9 cellline .u 36 to 444 1 to 409   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 409/409
(100 %)
0 diff
(100 %id)
CN306618 embryonic stem cells, DMSO-treated H9 cellline .u 39 to 440 1 to 402       402/402
(100 %)
0 diff
(100 %id)
BU500640   .u 39 to 444 2 to 405   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 404/405
(99 %)
6 diff
(98.6 %id)
CN306607 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .u 40 to 444 1 to 405   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 405/405
(100 %)
4 diff
(99.1 %id)
BG337381 leiomyosarcoma cell line, uterus .u 42 to 444 1 to 403   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 403/403
(100 %)
0 diff
(100 %id)
AA308546 colon .u 43 to 444 1 to 402       402/402
(100 %)
0 diff
(100 %id)
BX283606 leiomyosarcoma cell line, uterus .u 43 to 444 1 to 402   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 402/402
(100 %)
0 diff
(100 %id)
CD248819 embryonic stem cells, WA01, passage 38 .u 45 to 444 17 to 418   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 402/418
(96 %)
6 diff
(98.6 %id)
AI929159 brain, frontal lobe .u 47 to 428 1 to 382   fully sequenced,   382/382
(100 %)
3 diff
(99.3 %id)
AW161439 brain, frontal lobe .u 47 to 428 1 to 382   fully sequenced,   382/382
(100 %)
0 diff
(100 %id)
AL050273 Kidney .u 48 to 441 1 to 394   available from DKFZ, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 394/395
(99 %)
1 diff
(99.8 %id)
CB105662 Liver .u 48 to 418 9 to 379       371/371
(100 %)
0 diff
(100 %id)
CB112170 Liver .u 48 to 444 1 to 397   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 397/397
(100 %)
0 diff
(100 %id)
BP871033 embryonal kidney .u 49 to 380 1 to 332       332/332
(100 %)
0 diff
(100 %id)
BP871356 embryonal kidney .u 49 to 380 1 to 332       332/332
(100 %)
0 diff
(100 %id)
AK311990 thymus .u 49 to 400 1 to 352       352/352
(100 %)
0 diff
(100 %id)
CB127168 cervix, Uterine .u 49 to 444 1 to 396   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 396/396
(100 %)
0 diff
(100 %id)
CD247278 embryonic stem cells, WA01, passage 38 .u 49 to 653 18 to 621   tiling clone, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 604/621
(97 %)
7 diff
(98.9 %id)
AV710618 adrenal cortico adenoma for Cushing'ssyndrome .u 49 to 444 1 to 396   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 396/396
(100 %)
0 diff
(100 %id)
BJ991115 hepatoblastoma .u 49 to 408 1 to 360       360/360
(100 %)
0 diff
(100 %id)
BJ994778 hepatoblastoma .u 49 to 446 1 to 398   fully sequenced,   398/398
(100 %)
1 diff
(99.8 %id)
AV762734 bone marrow .u 49 to 444 1 to 396   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 396/396
(100 %)
0 diff
(100 %id)
AV762499 bone marrow .u 49 to 444 1 to 396   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 396/396
(100 %)
0 diff
(100 %id)
AV763969 bone marrow .u 49 to 444 1 to 396   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 396/396
(100 %)
0 diff
(100 %id)
BM788142 Ascites, stomach .u 49 to 473 1 to 425       425/425
(100 %)
0 diff
(100 %id)
BM788485 Ascites, stomach .u 49 to 475 1 to 427       427/427
(100 %)
0 diff
(100 %id)
BM788513 Ascites, stomach .u 49 to 475 1 to 427       427/427
(100 %)
0 diff
(100 %id)
BM843244 stomach .u 49 to 444 1 to 396   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 396/396
(100 %)
0 diff
(100 %id)
BM850290 stomach .u 49 to 441 1 to 393       393/393
(100 %)
0 diff
(100 %id)
BM855612 stomach .u 49 to 441 1 to 393       393/393
(100 %)
0 diff
(100 %id)
BQ084118 stomach .u 49 to 383 1 to 335       335/335
(100 %)
0 diff
(100 %id)
BM790823 stomach .u 49 to 469 1 to 421       421/421
(100 %)
0 diff
(100 %id)
BM851699 stomach .u 49 to 481 1 to 433       433/433
(100 %)
0 diff
(100 %id)
CN306608 embryonic stem cells, DMSO-treated H9 cellline .u 53 to 550 1 to 498       498/498
(100 %)
3 diff
(99.4 %id)
CN306613 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .u 54 to 440 1 to 387       387/387
(100 %)
0 diff
(100 %id)
CN306612 embryonic stem cells, DMSO-treated H9 cellline .u 55 to 444 4 to 393   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 390/393
(99 %)
6 diff
(98.5 %id)
BM511443 insulinoma, Pancreas .u 55 to 442 1 to 388   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 388/388
(100 %)
4 diff
(99.0 %id)
BU528415 epidermoid carcinoma, cell line, lung .u 55 to 654 1 to 601       601/603
(99 %)
2 diff
(99.7 %id)
AV761533 bone marrow .u 56 to 444 1 to 389   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 389/389
(100 %)
0 diff
(100 %id)
BM557089 amelanotic melanoma, cell line, skin .u 57 to 444 1 to 388   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 388/388
(100 %)
0 diff
(100 %id)
AJ709760 heart .u 58 to 582 1 to 529       529/529
(100 %)
2 diff
(99.7 %id)
CN306615 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .u 58 to 650 1 to 593       593/593
(100 %)
0 diff
(100 %id)
CN306617 embryonic stem cells, DMSO-treated H9 cellline .u 58 to 444 1 to 387   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 387/387
(100 %)
0 diff
(100 %id)
BI759280 pooled colon, kidney, stomach .u 58 to 444 1 to 387   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 387/387
(100 %)
0 diff
(100 %id)
BI769974 pooled lung and spleen .u 58 to 442 1 to 385   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 385/385
(100 %)
0 diff
(100 %id)
BI835426 pooled pancreas and spleen .u 58 to 444 1 to 387   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 387/387
(100 %)
0 diff
(100 %id)
BI833170 pooled pancreas and spleen .u 58 to 444 1 to 387   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 387/387
(100 %)
0 diff
(100 %id)
BI913279 brain .u 58 to 444 1 to 387   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 387/387
(100 %)
0 diff
(100 %id)
CR977610 T-Lymphocytes .u 58 to 490 1 to 433       433/433
(100 %)
0 diff
(100 %id)
CR992267 T-Lymphocytes .u 58 to 444 1 to 387   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 387/387
(100 %)
0 diff
(100 %id)
CR986603 T-Lymphocytes .u 58 to 444 1 to 387   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 387/387
(100 %)
0 diff
(100 %id)
CT003680 T-Lymphocytes .u 58 to 444 1 to 387   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 387/387
(100 %)
0 diff
(100 %id)
CR977947 T-Lymphocytes .u 58 to 444 1 to 387   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 387/387
(100 %)
0 diff
(100 %id)
CR977575 T-Lymphocytes .u 58 to 444 1 to 387   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 387/387
(100 %)
0 diff
(100 %id)
CT004117 T-Lymphocytes .u 58 to 504 1 to 447       447/449
(99 %)
3 diff
(99.4 %id)
CR989045 T-Lymphocytes .u 58 to 444 1 to 387   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 387/387
(100 %)
0 diff
(100 %id)
CR975952 T-Lymphocytes .u 58 to 444 1 to 387   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 387/387
(100 %)
0 diff
(100 %id)
BC004971 Kidney, renal cell adenocarcinoma .u 59 to 444 1 to 386   available from MGC, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 386/386
(100 %)
0 diff
(100 %id)
AI928949 brain, frontal lobe .u 59 to 433 1 to 375   fully sequenced, Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 375/375
(100 %)
1 diff
(99.8 %id)
AI929458 brain, frontal lobe .u 59 to 433 1 to 375   fully sequenced, Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 375/375
(100 %)
1 diff
(99.8 %id)
BG748327 eye, normal pigmented retinal epithelium .u 59 to 444 1 to 386   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 386/386
(100 %)
0 diff
(100 %id)
BG752946 eye, normal pigmented retinal epithelium .u 59 to 444 1 to 386   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 386/386
(100 %)
0 diff
(100 %id)
BI858727 breast, mammary adenocarcinoma, cell line .u 59 to 444 1 to 386   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 386/386
(100 %)
0 diff
(100 %id)
BQ066954 brain .u 59 to 444 1 to 386   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 386/386
(100 %)
0 diff
(100 %id)
BQ230941 epithelioid carcinoma, Pancreas .u 59 to 444 1 to 386   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 386/386
(100 %)
0 diff
(100 %id)
CD513458 brain, Pituitary .u 59 to 444 1 to 386   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 386/386
(100 %)
0 diff
(100 %id)
DN993142 brain, whole brain .u 59 to 652 8 to 601       594/601
(98 %)
6 diff
(99.1 %id)
BE336835 Kidney, renal cell adenocarcinoma .u 60 to 424 1 to 364   fully sequenced,   364/364
(100 %)
1 diff
(99.8 %id)
BG339095 leiomyosarcoma cell line, uterus .u 60 to 444 1 to 385   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 385/385
(100 %)
0 diff
(100 %id)
BU162409 melanotic melanoma, cell line, skin .u 60 to 444 1 to 385   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 385/385
(100 %)
0 diff
(100 %id)
BQ683565 melanotic melanoma, cell line, skin .u 60 to 442 1 to 383   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 383/385
(99 %)
1 diff
(99.8 %id)
BQ683496 melanotic melanoma, cell line, skin .u 60 to 442 1 to 383   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 383/385
(99 %)
1 diff
(99.8 %id)
BQ648428 hepatocellular carcinoma, cell line, Liver .u 60 to 444 1 to 385   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 385/385
(100 %)
0 diff
(100 %id)
BQ950113 large cell carcinoma, lung .u 60 to 444 1 to 385   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 385/385
(100 %)
0 diff
(100 %id)
BU538486 adenocarcinoma, cell line, breast .u 60 to 444 1 to 385   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 385/385
(100 %)
0 diff
(100 %id)
BU557175 ovary, teratocarcinoma, cell line .u 60 to 444 1 to 385   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 385/385
(100 %)
0 diff
(100 %id)
BU849726 ovary, teratocarcinoma, cell line .u 60 to 444 1 to 385   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 385/385
(100 %)
0 diff
(100 %id)
BU956561 adenocarcinoma, cell line, breast .u 60 to 444 1 to 385   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 385/385
(100 %)
0 diff
(100 %id)
BM888394 eye .u 61 to 442 1 to 382   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 382/382
(100 %)
0 diff
(100 %id)
AI815607 brain, frontal lobe .u 61 to 425 1 to 365   fully sequenced,   365/365
(100 %)
0 diff
(100 %id)
AI879102 brain, frontal lobe .u 61 to 428 1 to 368   fully sequenced,   368/368
(100 %)
0 diff
(100 %id)
AW160712 brain, frontal lobe .u 61 to 428 1 to 368   fully sequenced,   368/368
(100 %)
0 diff
(100 %id)
AW163757 brain, frontal lobe .u 61 to 425 1 to 365   fully sequenced,   365/365
(100 %)
0 diff
(100 %id)
BM919203 pooled pancreas and spleen .u 61 to 442 6 to 387   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 382/389
(98 %)
7 diff
(98.3 %id)
BQ052666 blood, natural killer cells, cell line .u 61 to 442 1 to 382   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 382/384
(99 %)
1 diff
(99.8 %id)
CN306597 embryonic stem cells, DMSO-treated H9 cellline .u 62 to 442 1 to 381       381/381
(100 %)
0 diff
(100 %id)
AW163676 brain, frontal lobe .u 62 to 428 1 to 367   fully sequenced,   367/367
(100 %)
0 diff
(100 %id)
BI524136 pooled lung and spleen .u 62 to 442 1 to 381   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 381/381
(100 %)
0 diff
(100 %id)
BI768985 pooled lung and spleen .u 62 to 444 1 to 383   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 383/383
(100 %)
0 diff
(100 %id)
CX165592 human embryonic stem cells differentiated toan early endodermal cell type .u 62 to 442 1 to 381   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 381/383
(99 %)
1 diff
(99.8 %id)
CT001007 T-Lymphocytes .u 62 to 442 1 to 381   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 381/383
(99 %)
1 diff
(99.8 %id)
BP384990 pancreatic islet .u 63 to 444 382 to 1       382/382
(100 %)
0 diff
(100 %id)
CD513618 brain, Pituitary .u 63 to 444 1 to 382   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 382/382
(100 %)
0 diff
(100 %id)
BU174273 ductal carcinoma, cell line, Pancreas .u 64 to 444 1 to 381   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 381/381
(100 %)
0 diff
(100 %id)
BM740105 Ascites, stomach .u 65 to 444 1 to 380   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 380/380
(100 %)
0 diff
(100 %id)
BG770034 melanotic melanoma, high MDR (cell line), skin .u 66 to 651 1 to 586   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 586/586
(100 %)
1 diff
(99.9 %id)
AA305999   .u 67 to 444 1 to 378       378/378
(100 %)
0 diff
(100 %id)
AA315107 colon .u 67 to 409 1 to 343       343/343
(100 %)
0 diff
(100 %id)
BG696263 skin .u 67 to 444 1 to 378   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 378/378
(100 %)
0 diff
(100 %id)
BI836211 pooled pancreas and spleen .u 67 to 444 1 to 378   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 378/378
(100 %)
0 diff
(100 %id)
BI856489 breast, mammary adenocarcinoma, cell line .u 67 to 589 1 to 523       523/523
(100 %)
1 diff
(99.9 %id)
TI_59383942   .u 67 to 652 59 to 646       588/696
(84 %)
5 diff
(99.3 %id)
BM550410 amelanotic melanoma, cell line, skin .u 68 to 444 1 to 377   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 377/377
(100 %)
0 diff
(100 %id)
F20887 pectoral muscle (after mastectomy) .u 69 to 442 1 to 374       374/374
(100 %)
0 diff
(100 %id)
BP430077   .u 69 to 436 4 to 371       368/371
(99 %)
0 diff
(100 %id)
BF971602 leiomyosarcoma cell line, uterus .u 70 to 444 1 to 375   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 375/375
(100 %)
0 diff
(100 %id)
BG437530 large cell carcinoma, lung .u 71 to 444 1 to 374   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 374/374
(100 %)
0 diff
(100 %id)
BQ067537 pooled brain, lung, testis .u 71 to 444 1 to 374   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 374/374
(100 %)
0 diff
(100 %id)
BQ949454 large cell carcinoma, lung .u 71 to 444 1 to 374   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 374/374
(100 %)
0 diff
(100 %id)
BM783961 Ascites, stomach .u 72 to 444 1 to 373   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 373/373
(100 %)
0 diff
(100 %id)
BM770222 Ascites, stomach .u 72 to 444 1 to 373   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 373/373
(100 %)
0 diff
(100 %id)
AA320816 adipose tissue, white .u 75 to 341 1 to 267       267/267
(100 %)
0 diff
(100 %id)
BU955919 adenocarcinoma, cell line, breast .u 75 to 442 1 to 368   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 368/370
(99 %)
1 diff
(99.8 %id)
CR613397 Placenta Cot 25-normalized .u 77 to 446 1 to 370       370/370
(100 %)
0 diff
(100 %id)
BX353267 Neuroblastoma Cot 25-normalized .u 77 to 446 1 to 370       370/370
(100 %)
0 diff
(100 %id)
BJ994779 hepatoblastoma .u 145 to 411 267 to 1   fully sequenced,   267/267
(100 %)
0 diff
(100 %id)
AI937913 brain, frontal lobe .u 145 to 446 307 to 6   fully sequenced,   302/307
(98 %)
0 diff
(100 %id)
AI929203 brain, frontal lobe .u 145 to 444 312 to 13   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 300/300
(100 %)
1 diff
(99.7 %id)
AI929416 brain, frontal lobe .u 145 to 444 312 to 13   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 300/300
(100 %)
2 diff
(99.4 %id)
AW162217 brain, frontal lobe .u 145 to 446 307 to 6   fully sequenced,   302/307
(98 %)
0 diff
(100 %id)
AW156973 brain, frontal lobe .u 145 to 446 307 to 6   fully sequenced,   302/307
(98 %)
0 diff
(100 %id)
AW157680 brain, frontal lobe .u 145 to 446 307 to 6   fully sequenced,   302/307
(98 %)
0 diff
(100 %id)
AW157724 brain, frontal lobe .u 145 to 446 307 to 6   fully sequenced,   302/307
(98 %)
0 diff
(100 %id)
BE208057 Kidney, renal cell adenocarcinoma .u 145 to 446 306 to 5   fully sequenced,   302/306
(98 %)
0 diff
(100 %id)
BI524720 pooled lung and spleen .u 145 to 392 248 to 1   fully sequenced, Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 248/248
(100 %)
2 diff
(99.2 %id)
BM510609 insulinoma, Pancreas .u 145 to 444 323 to 24   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 300/300
(100 %)
1 diff
(99.7 %id)
AI815885 brain, frontal lobe .u 158 to 446 294 to 6   fully sequenced,   289/294
(98 %)
0 diff
(100 %id)
BG942567 blood .u 171 to 446 304 to 29       276/304
(90 %)
0 diff
(100 %id)
BM687452.
matches multiple genes
eye, eye anterior segment .u 181 to 444 1 to 264   AAA Possibly primed on the genome, locally A rich (20/23 A in genome downstream of last aligned base), also hits gene RPL36P3 264/264
(100 %)
0 diff
(100 %id)
EL949359 eyeball .u 190 to 653 1 to 463   tiling clone, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 463/463
(100 %)
3 diff
(99.4 %id)
F22482 pectoral muscle (after mastectomy) .u 200 to 385 1 to 186       186/186
(100 %)
0 diff
(100 %id)
AI991245 colon, colonic mucosa from 3 patients with Crohn'sdisease .u 207 to 652 446 to 1       446/446
(100 %)
1 diff
(99.8 %id)
F16990 pectoral muscle (after mastectomy) .u 211 to 445 1 to 235       235/235
(100 %)
0 diff
(100 %id)
CR980502 T-Lymphocytes .u 218 to 444 1 to 227   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 227/227
(100 %)
0 diff
(100 %id)
CT003813 T-Lymphocytes .u 218 to 442 1 to 225   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 225/225
(100 %)
0 diff
(100 %id)
CR991131 T-Lymphocytes .u 218 to 444 1 to 227   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 227/227
(100 %)
0 diff
(100 %id)
AI688209 colon .u 221 to 652 432 to 1       432/432
(100 %)
1 diff
(99.8 %id)
CN446894 stomach .u 240 to 360 1 to 121       121/121
(100 %)
0 diff
(100 %id)
BM783885 stomach .u 244 to 442 1 to 199   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 199/199
(100 %)
0 diff
(100 %id)
AA514522 colon .u 246 to 444 199 to 1       199/199
(100 %)
0 diff
(100 %id)
AA328203   .u 253 to 444 1 to 192       192/192
(100 %)
0 diff
(100 %id)
AA531014 normal prostate, Prostate .u 264 to 444 181 to 1       181/181
(100 %)
0 diff
(100 %id)
EC460150 Prostate .u 286 to 388 2 to 103       102/103
(99 %)
6 diff
(94.2 %id)
EC543205 Prostate .u 295 to 397 1 to 103       103/103
(100 %)
0 diff
(100 %id)
EC468033 Prostate .u 321 to 421 1 to 101       101/101
(100 %)
0 diff
(100 %id)
F29292 pectoral muscle (after mastectomy) .u 329 to 563 1 to 235       235/235
(100 %)
0 diff
(100 %id)
AI459942 colon .u 333 to 440 108 to 1       108/108
(100 %)
0 diff
(100 %id)
EC466875 Prostate .u 346 to 446 107 to 7       101/107
(94 %)
0 diff
(100 %id)
EC572708 Prostate .u 346 to 443 100 to 3       98/100
(98 %)
0 diff
(100 %id)
AI928906 brain, frontal lobe .u 353 to 395 43 to 1   fully sequenced,   43/43
(100 %)
0 diff
(100 %id)
AA688244 normal prostate, Prostate .u 374 to 444 83 to 13   AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 71/71
(100 %)
0 diff
(100 %id)
TI_57239949   .va 1 to 740 53 to 793 exact tiling clone,   741/793
(93 %)
7 diff
(99.2 %id)
BI916415 brain .va 6 to 740 1 to 735 exact tiling clone,   735/735
(100 %)
1 diff
(99.9 %id)
BI548193 brain, hippocampus .vb 1 to 713 1 to 713 R41Q tiling clone,   713/713
(100 %)
4 diff
(99.5 %id)
TI_57241694   .vc 1 to 709 29 to 755   tiling clone,   723/1088
(66 %)
49 diff
(95.5 %id)
BI914247 brain .vc 8 to 709 1 to 721   tiling clone,   717/1054
(68 %)
42 diff
(96.1 %id)
BM928156 brain .vc 26 to 822 1 to 803 V74G V75G V76G S77G S78L ... tiling clone,   803/1112
(72 %)
16 diff
(98.6 %id)
CD175037 embryonic stem cells, WA01, passage 38 .vd 1 to 424 24 to 448 exact tiling clone, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 433/448
(96 %)
6 diff
(98.7 %id)
BC062777 lung .ve 1 to 690 1 to 690 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 690/690
(100 %)
1 diff
(99.9 %id)
BG484052 lung .ve 4 to 702 1 to 718 A25D S26Q L27P Q28P T62I ... available from MGC,   718/726
(98 %)
44 diff
(94.0 %id)
BC018336 Ovary, adenocarcinoma .ve 141 to 690 1 to 550 exact available from MGC, AAA Possibly primed on the genome, locally A rich (21/25 A in genome downstream of last aligned base) 550/550
(100 %)
0 diff
(100 %id)
BF036568 adenocarcinoma, ovary .ve 158 to 710 2 to 582 G8W L9A A11V L12P F13C ... available from MGC,   581/597
(97 %)
45 diff
(92.5 %id)
AI436330 pooled .ve 299 to 729 431 to 1       431/431
(100 %)
1 diff
(99.8 %id)
AI554725 anaplastic oligodendroglioma, brain .ve 302 to 724 423 to 1       423/426
(99 %)
0 diff
(100 %id)
CA488111   .vf 1 to 856 1 to 866 exact tiling clone,   866/928
(93 %)
34 diff
(96.4 %id)
AI476367 pooled .vf 778 to 1184 408 to 2   tiling clone,   407/408
(99 %)
0 diff
(100 %id)
DB498796 hypothalamus .vg 1 to 503 1 to 503 exact tiling clone,   503/503
(100 %)
1 diff
(99.9 %id)
DB481451 hippocampus .vg 29 to 502 1 to 474 exact tiling clone,   474/474
(100 %)
0 diff
(100 %id)
CB107382 Liver .vh 1 to 399 1 to 399 G12C R84S tiling clone,   399/399
(100 %)
2 diff
(99.5 %id)
AA598734 lung, lung carcinoma .vi-u 1 to 389 388 to 1 L48S T49R V51* tiling clone,   388/388
(100 %)
1 diff
(99.8 %id)
BM805139 ovary (pool of 3) Gene HSD11B1LandRPL36, variant not shown              
223 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh, .vi-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI